Attenuated varicella-zoster virus

Therapeutic indications

Attenuated varicella-zoster virus is indicated for:

Herpes zoster, post-herpetic neuralgia (PHN)

Population group: only adults (18 years old or older)

Varicella-zoster virus is indicated for prevention of herpes zoster (“zoster” or shingles) and herpes zoster-related post-herpetic neuralgia (PHN).

It is indicated for immunization of individuals 50 years of age or older.

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Contraindications

Attenuated varicella-zoster virus is contraindicated in the following cases:

Pregnancy

Pregnancy

Primary immunodeficiency states, acquired immunodeficiency states

at least one of
Primary immune deficiency disorder
AIDS

Immunosuppressants, corticosteroids

at least one of
Immunosuppressants
Corticosteroid drugs

Active tuberculosis

Active tuberculosis

Get recommendations

Factors such as age, gender, and health history are evaluated to create a personalized medication regimen.

Ask the Reasoner

Related medicines

Summary of Product Characteristics (SPC) 2022: ZOSTAVAX Powder and solvent for suspension for injection
< Previous: Overview
Next: Precautions >

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.

⇈